Lummus and RWDC Link on Polyhydroxyalkanoates

Lummus Technology and US biotech RWDC Industries have signed a Memorandum of Understanding to cooperate on deploying polyhydroxyalkanoates (PHAs), a group of natural biodegradable polyesters that are a sustainable alternative to fossil-based plastics.

The collaboration combining Lummus’ expertise in process technology and RWDC’s expertise in PHA production and application is intended to significantly accelerate global availability and mass adoption of PHAs through global licensing opportunities. RWDC uses plant-based oils, including post-consumer or waste cooking oils, to produce its proprietary Solon PHA, which can be organically recycled or composted.

“We are excited to combine Lummus and RWDC’s collective expertise, experience and resources to commercialize PHAs, a sustainable and economic solution to help address global plastic waste,” said Lummus president and CEO Leon de Bruyn. “Together, we can provide eco-friendly biodegradable plastics, while driving innovation and advancing the circular economy of our industry.”

Leon de Bruyn, CEO Lummus (left)  and Daniel Carraway (right), CEO and founder,...
Leon de Bruyn, CEO Lummus (left) and Daniel Carraway (right), CEO and founder, RWDC Industries © Lummus Technology

In June 2021, RWDC announced a collaboration with US multinational personal care giant Kimberly-Clark, which aims to cut the use of fossil-based plastics by half by 2030.  Under the deal, the companies agreed to jointly develop personal care products featuring RWDC’s Solon PHA over the next five years.

Author: Elaine Burridgeeee, Freelance Journalist

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis